Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis

Antonio Craxi, Salvatore Petta, Grazia Pennisi, Valerio Nobili, Raffaela Rametta, Sara Badiali, Serena Pelusi, Chiara Rosso, Ville Mannisto, Valerio Nobili, Guido Baselli, Annalisa Cespiati, Stefano Romeo, Luca Valenti, Luca Valenti, Paola Dongiovanni, Elisabetta Bugianesi, Anna Ludovica Fracanzani, Jussi Pihlajamaki, Marco MaggioniLuca Valenti, Silvia Fargion, Daniele Prati, Ludovica Pilar Valenti

Risultato della ricerca: Articlepeer review

32 Citazioni (Scopus)

Abstract

In patients with nonalcoholic fatty liver disease (NAFLD), steatohepatitis (NASH) is a risk factor for development of fibrosis. However, fibrosis has been observed in livers of patients without NASH. We aimed to estimate the prevalence of fibrosis in patients without NASH and risk factors for fibrosis.
Lingua originaleEnglish
Numero di pagine46
RivistaClinical Gastroenterology and Hepatology
Stato di pubblicazionePublished - 2019

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2721???
  • ???subjectarea.asjc.2700.2715???

Fingerprint

Entra nei temi di ricerca di 'Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis'. Insieme formano una fingerprint unica.

Cita questo